stromectol 3mg, with its active ingredient ivermectin, has been investigated for its potential role in controlling parasitic infections in wildlife populations. Conservation efforts aimed at protecting endangered species from the threat of parasitic diseases may benefit from the development of targeted treatment strategies utilizing ivermectin-based interventions.
